# MAVENCLAD
> **NDA022561** · New Drug Application · Sponsor: EMD SERONO INC · Approved 2019-03-29
## Drug
- **FDA Application Number:** NDA022561
- **Application type:** New Drug Application
- **Brand name:** MAVENCLAD
- **Generic name:** CLADRIBINE
- **Active ingredients:** CLADRIBINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EMD SERONO INC
- **Manufacturer:** EMD Serono, Inc.
- **First approval:** 2019-03-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022561)
---
*AI Analytics · CC0 1.0*